Hertz D - Search Results

1

Using maximum plasma concentration (C_max) to personalize taxane treatment and reduce toxicity.

Sun Y, Cheng Y, Hertz DL. Sun Y, et al. Among authors: hertz dl. Cancer Chemother Pharmacol. 2024 Jun;93(6):525-539. doi: 10.1007/s00280-024-04677-1. Epub 2024 May 11. Cancer Chemother Pharmacol. 2024. PMID: 38734836 Review.

2

Recommendations for pharmacogenetic testing in clinical practice guidelines in the US.

Hertz DL, Bousman CA, McLeod HL, Monte AA, Voora D, Orlando LA, Crutchley RD, Brown B, Teeple W, Rogers S, Patel JN. Hertz DL, et al. Am J Health Syst Pharm. 2024 Apr 23:zxae110. doi: 10.1093/ajhp/zxae110. Online ahead of print. Am J Health Syst Pharm. 2024. PMID: 38652504

3

Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations.

Hertz DL, Joerger M, Bang YJ, Mathijssen RH, Zhou C, Zhang L, Gandara D, Stahl M, Monk BJ, Jaehde U, Beumer JH. Hertz DL, et al. Eur J Cancer. 2024 May;202:114024. doi: 10.1016/j.ejca.2024.114024. Epub 2024 Mar 19. Eur J Cancer. 2024. PMID: 38513383 Review.

4

Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort.

Mc Laughlin AM, Helland T, Klima F, Koolen SLW, van Schaik RHN, Mathijssen RHJ, Neven P, Swen JJ, Guchelaar HJ, Dalenc F, White-Koning M, Michelet R, Mikus G, Schroth W, Mürdter T, Brauch H, Schwab M, Søiland H, Mellgren G, Thomas F, Kloft C, Hertz DL; CYP2D6 Endoxifen Percentage Activity Model (CEPAM) Consortium. Mc Laughlin AM, et al. Among authors: hertz dl. Clin Pharmacol Ther. 2024 Mar 18. doi: 10.1002/cpt.3238. Online ahead of print. Clin Pharmacol Ther. 2024. PMID: 38494911

5

Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance).

Patel JN, Jiang C, Owzar K, Hertz DL, Wang J, Mulkey FA, Kelly WK, Halabi S, Furukawa Y, Lassiter C, Dorsey SG, Friedman PN, Small EJ, Carducci MA, Kelley MJ, Nakamura Y, Kubo M, Ratain MJ, Morris MJ, McLeod HL. Patel JN, et al. Among authors: hertz dl. Pharmacogenomics J. 2024 Mar 4;24(2):6. doi: 10.1038/s41397-024-00328-z. Pharmacogenomics J. 2024. PMID: 38438359 Free PMC article.

6

Comparative Costs to Medicare and Medicare Beneficiaries of Alternative AF Stroke Risk Reduction Strategies.

Reddy VY, Zhong Y, McGovern AM, Amorosi SL, Gavaghan MB, Hertz DS, Low K, Freeman S, Holmes DR Jr. Reddy VY, et al. Among authors: hertz ds. Clinicoecon Outcomes Res. 2024 Feb 14;16:81-96. doi: 10.2147/CEOR.S440556. eCollection 2024. Clinicoecon Outcomes Res. 2024. PMID: 38374959 Free PMC article.

7

Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptoms.

Liang Y, Gersch CL, Lehman J, Henry NL, Smith KL, Rae JM, Stearns V, Hertz DL. Liang Y, et al. Among authors: hertz dl. Pharmacogenet Genomics. 2024 Jun 1;34(4):126-129. doi: 10.1097/FPC.0000000000000522. Epub 2024 Feb 8. Pharmacogenet Genomics. 2024. PMID: 38359166

8

Incorporation of emergent symptoms and genetic covariates improves prediction of aromatase inhibitor therapy discontinuation.

Rattsev I, Stearns V, Blackford AL, Hertz DL, Smith KL, Rae JM, Taylor CO. Rattsev I, et al. Among authors: hertz dl. JAMIA Open. 2024 Jan 19;7(1):ooae006. doi: 10.1093/jamiaopen/ooae006. eCollection 2024 Apr. JAMIA Open. 2024. PMID: 38250582 Free PMC article.

9

Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy.

Hertz DL, Tofthagen C, Rossi E, Bernasconi DP, Lim J, Carlson M, Sheffield KE, Nekhlyudov L, Grech L, Von Ah D, Mayo SJ, Ruddy KJ, Chan A, Alberti P, Lustberg MB, Tanay M. Hertz DL, et al. Support Care Cancer. 2023 Dec 22;32(1):48. doi: 10.1007/s00520-023-08209-0. Support Care Cancer. 2023. PMID: 38129602

10

Incidence, description, predictors, and consequences of persistent taxane-induced peripheral neuropathy.

Hertz DL. Hertz DL. Curr Opin Support Palliat Care. 2024 Mar 1;18(1):30-38. doi: 10.1097/SPC.0000000000000684. Epub 2024 Dec 6. Curr Opin Support Palliat Care. 2024. PMID: 38126251 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

221 results

Search Page